Breast Cancer Health Center
Breast Cancer - What Increases Your Risk
Although the exact cause of breast cancer is not known, most experts agree that there are several factors that increase your risk of breast cancer.
Top risk factors linked to breast cancer
Aging. Your risk of breast cancer increases as you get older. By age group, breast cancer is diagnosed in:2
- 4 out of 1,000 women in their 30s.
- 15 out of 1,000 women in their 40s.
- 26 out of 1,000 women in their 50s.
- 37 out of 1,000 women in their 60s.
Being female. Although breast cancer can occur in men, most breast cancer is found in women.
Conditions that increase the risk of developing breast cancer
Personal history of breast cancer. Women who have had breast cancer in one breast have an increased chance of having another breast cancer. The breast cancer can come back in the same breast, in the opposite breast, or in other areas of the body, such as the lungs, liver, brain, or bones.
Family history. A woman's risk of breast cancer increases if her mother, sister, daughter, or two or more other close relatives, such as cousins, have a history of breast cancer, especially if they were diagnosed with breast cancer before age 50.
- Women who inherit specific changes (genetic mutations) in the BRCA1 and BRCA2 genes are much more likely to have breast cancer. They are also more likely to have colon or ovarian cancer. But most women who have a family history of breast cancer do not have changes in BRCA genes.
- Mutations in the BRCA1 and BRCA2 genes are more common in certain ethnic groups, such as Ashkenazi Jews.9
- Genetic tests are available to determine whether you have the genetic mutations long before any cancer appears. In families where many women have had breast or ovarian cancer, genetic testing can show whether a woman has specific genetic changes known to greatly increase the risk of breast cancer. Doctors may suggest ways to try to prevent or delay breast cancer or to improve the detection of breast cancer in women who have the genetic mutations. For more information, see:
Breast changes. Women who have atypical hyperplasia, ductal carcinoma in situ (DCIS), or lobular carcinoma in situ (LCIS) or who have had two or more breast biopsies for other noncancerous conditions are more likely to have breast cancer.
Other factors that increase the risk of breast cancer
Race. In the United States, breast cancer occurs more frequently in white women than in black, Hispanic, or Asian women. But black women are more likely to get breast cancer at a younger age and are also more likely to die of breast cancer.10 This may be linked in part to genetic differences-an aggressive type of breast cancer called basal-like tumor seems most likely to affect young African-American women. Lower survival rates among black women may also be linked to lower quality health care.11
WebMD Medical Reference from Healthwise
Breast Cancer Topics
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

